U.S. Physical Therapy (NYSE:USPH) Lowered to Sell Rating by StockNews.com

U.S. Physical Therapy (NYSE:USPH) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Thursday.

USPH has been the subject of a number of other reports. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. cut their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. One analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Stock Performance

USPH opened at $68.57 on Thursday. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $108.14. The stock has a market cap of $1.04 billion, a PE ratio of 72.95, a price-to-earnings-growth ratio of 3.54 and a beta of 1.38. The business’s 50 day moving average is $77.24 and its 200-day moving average is $85.00. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. On average, analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of the business. State Street Corp lifted its position in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares in the last quarter. Geode Capital Management LLC lifted its position in U.S. Physical Therapy by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after buying an additional 4,477 shares in the last quarter. HighTower Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 13.6% during the 3rd quarter. HighTower Advisors LLC now owns 4,714 shares of the company’s stock valued at $399,000 after buying an additional 566 shares during the period. PNC Financial Services Group Inc. grew its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company’s stock valued at $409,000 after acquiring an additional 1,254 shares in the last quarter. Finally, Copeland Capital Management LLC increased its stake in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after acquiring an additional 72,715 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.